# A Randomized Trial to Evaluate Efficacy and Safety of Intracavernosal Injection of Platelet-Rich Plasma Versus Phosphodiesterase Type-5 Inhibitors for Treatment of Erectile Dysfunction.

> **NCT05787769** · NA · UNKNOWN · sponsor: **Mansoura University** · enrollment: 96 (estimated)

## Conditions studied

- Erectile Dysfunction Following Radiation Therapy
- Phosphodiesterase Inhibitor Adverse Reaction
- Platelet- Rich Plasma (PRP)

## Interventions

- **DRUG:** P shot arm ( Autologous Platelet Rich Plasma)
- **DRUG:** PDE5i arm

## Key facts

- **NCT ID:** NCT05787769
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2025-01-25
- **Final completion:** 2025-01-25
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05787769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05787769, "A Randomized Trial to Evaluate Efficacy and Safety of Intracavernosal Injection of Platelet-Rich Plasma Versus Phosphodiesterase Type-5 Inhibitors for Treatment of Erectile Dysfunction.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05787769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*